Buscar

07/03/2023 Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding
Rudler, M, Hernandez-Gea, V, Procopet, BD, Giraldez, A, Amitrano, L, Villanueva, C, Ibanez, L, Silva, G, Genesca, J, Bureau, C, Trebicka, J, Banares, R, Krag, A, Llop, E, Laleman, W, Palazon, JM, Castellote, J, Rodrigues, S, Gluud, LL, Ferreira, CN, Canete, N, Rodriguez, M, Ferlitsch, A, Mundi, JL, Gronbaek, H, Hernandez-Guerra, M, Sassatelli, R, Dell'era, A, Senzolo, M, Abraldes, JG, Romero-Gomez, M, Zipprich, A, Casas, M, Masnou, H, Larrue, H, Primignani, M, Nevens, F, Calleja, JL, Schwarzer, R, Jansen, C, Robic, MA, Conejo, I, Gonzalez, JM, Catalina, MV, Albillos, A, Alvarado, E, Guardascione, MA, Mallet, M, Tripon, S, Casanovas, G, Bosch, J, Garcia-Pagan, JC, Thabut, D. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding. GUT. 2023; 72(4)DOI:10.1136/gutjnl-2022-326975. PMID:36328772. IF:23.100(Q1/1D).
27/01/2023 Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Casas-Deza D., Lamuela-Calvo L.J., Gomollón F., Arbonés-Mainar J.M., Caballol B., Gisbert J.P., Rivero M., Sánchez-Rodríguez E., García L.A., Casbas A.G., Merino O., Márquez L., Laredo V., Martín-Arranz M.D., Serrano P.L., Menéndez S.R., González-Muñoza C., Parga, LD, Moya M.C., Fuentes-Valenzuela E., Esteve M., Iborra M., Gil M.D., Barreiro-De Acosta, M, Lorente-Poyatos R.H., Mancenido, N, Calafat M., Rodríguez-Lago I., Capo J.G., Payeras M.A., Alvarado, VJM, Tardillo C., Bujanda L., Munoz-Nunez, JF, Nieto Y.B., Bermejo F., Almela P., Navarro-Llavat M., Montiel P.M., Gutiérrez C.R., Van Domselaar M., Sesé E., Pérez T.M., Ricart E., Chaparro M., García M.J., López-Sanromán A., Sicilia B., Orts B., López-García A., Martín-Arranz E., Pérez-Calle J.L., de Francisco R., García-Planella E., Domenech, E, García-López S.. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry. Journal of Crohns & Colitis. 2023; 17(1)DOI:10.1093/ecco-jcc/jjac108. PMID:35913456. IF:8.300(Q1/1D).
01/10/2022 Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients
Gil-Gomez, A, Rojas, A, Garcia-Lozano, MR, Munoz-Hernandez, R, Gallego-Duran, R, Maya-Miles, D, Montero-Vallejo, R, Gato, S, Gallego, J, Frances, R, Soriano, G, Ampuero, J, Romero-Gomez, M. Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(19)DOI:10.3390/ijms231911840. PMID:36233142. IF:5.600(Q1/3D).
01/10/2022 Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (vol 10, 2885, 2021)
Chaparro, M, Garre, A, Ortiz, AN, Palomares, MTDL, Rodriguez, C, Riestra, S, Vela, M, Benitez, JM, Salgado, EF, Rodriguez, ES, Hernandez, V, Ferreiro-Iglesias, R, Diaz, AP, Barrio, J, Huguet, JM, Sicilia, B, Martin-Arranz, MD, Calvet, X, Ginard, D, Alonso-Abreu, I, Fernandez-Salazar, L, Trastoy, PV, Rivero, M, Vera-Mendoza, I, Vega, P, Navarro, P, Sierra, M, Cabriada, JL, Aguas, M, Vicente, R, Navarro-Llavat, M, Echarri, A, Gomollon, F, del Rio, EG, Pinero, C, Casanova, MJ, Spicakova, K, de Zarate, JO, Cortes, ET, Gutierrez, A, Alonso-Galan, H, Hernandez-Martinez, A, Marrero, JM, Poyatos, RL, Calafat, M, Romero, LM, Robledo, P, Bosch, O, Jimenez, N, Comas, ME, Duque, JM, Coronel, AMF, Sampedro, MJ, Abizanda, ES, Martinez, BH, Pozzati, L, Rosaenz, HF, Suarez, BC, Serrano, PL, Lucendo, AJ, Vicente, MM, Bermejo, F, Palanca, JJR, Menacho, M, Carmona, A, Camargo, R, Alsina, ST, Maroto, N, de la Puerta, JN, Castro, E, Marin-Jimenez, I, Botella, B, Sapina, A, Cruz, N, Forcelledo, JLF, Bouhmidi, A, Castano-Milla, C, Opio, V, Nicolas, I, Kutz, M, Bechiarelli, AA, Gordillo, J, Ber, Y, Dominguez, YT, Duran, MTN, Mondejar, SR, Martinez-Cerezo, FJ, Kolle, L, Sabat, M, Ledezma, C, Iyo, E, Roncero, O, Irisarri, R, Lluis, L, Gomez, IB, Zapata, EM, Alcala, MJ, Pascual, CM, Montealegre, M, Mata, L, Monrobel, A, Camba, AH, Hernandez, L, Tejada, M, Mir, A, Galve, ML, Soler, M, Hervias, D, Gomez-Valero, JA, Acosta, MBD, Rodriguez-Artalejo, F, Garcia-Esquinas, E, Gisbert, JP. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (vol 10, 2885, 2021). Journal of Clinical Medicine. 2022; 11(19)DOI:10.3390/jcm11195816. PMID:36233844. IF:3.900(Q2/4D).
01/10/2022 Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis
Villanueva, C, Torres, F, Sarin, SK, Shah, HA, Tripathi, D, Brujats, A, Rodrigues, SG, Bhardwaj, A, Azam, Z, Hayes, PC, Jindal, A, Abid, S, Alvarado, E, Bosch, J, Carvedilol IPD MA Grp, Baveno Cooperation EASL Consortium. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis. JOURNAL OF HEPATOLOGY. 2022; 77(4)DOI:10.1016/j.jhep.2022.05.021. PMID:35661713. IF:25.700(Q1/1D).
21/09/2022 Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease
Casado-Llombart, S, Velasco-de Andres, M, Catala, C, Leyton-Pereira, A, Gutierrez-Cozar, R, Suarez, B, Armiger, N, Carreras, E, Esteller, M, Ricart, E, Ordas, I, Gisbert, JP, Chaparro, M, Esteve, M, Marquez, L, Busquets, D, Iglesias, E, Garcia-Planella, E, Martin-Arranz, MD, Lohmann, J, Ayata, CK, Niess, JH, Engel, P, Panes, J, Salas, A, Domenech, E, Lozano, F. Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.966184. PMID:36211446. IF:7.300(Q1/3D).